Literature DB >> 1396435

Lidocaine in refractory status epilepticus: confirmation of efficacy with continuous EEG monitoring.

C M De Giorgio1, K Altman, E Hamilton-Byrd, A L Rabinowicz.   

Abstract

Lidocaine was efficacious in 2 patients with refractory status epilepticus (RSE) unresponsive to several antiepileptic drugs (AEDs), including high-dose barbiturates. We confirmed the efficacy of lidocaine with, for the first time in adults, continuous EEG monitoring. Lidocaine, when properly used, may be a treatment option in RSE.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1396435     DOI: 10.1111/j.1528-1157.1992.tb02200.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  3 in total

Review 1.  Emergency department drug therapy for status epilepticus in adults.

Authors:  A S Lockey
Journal:  Emerg Med J       Date:  2002-03       Impact factor: 2.740

2.  Status Epilepticus.

Authors:  Elizabeth J. Waterhouse
Journal:  Curr Treat Options Neurol       Date:  2002-07       Impact factor: 3.598

3.  Treatment of Super-Refractory Status Epilepticus: A Review.

Authors:  Juan G Ochoa; Michelle Dougherty; Alex Papanastassiou; Barry Gidal; Ismail Mohamed; David G Vossler
Journal:  Epilepsy Curr       Date:  2021-03-10       Impact factor: 7.500

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.